Tinostamustine Conditioning and Autologous Stem Cell
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Tinostamustine Conditioning and Autologous Stem Cell is a clinical trial[1].
Key Facts
- Tinostamustine Conditioning and Autologous Stem Cell is in the country of Norway[2].
- Tinostamustine Conditioning and Autologous Stem Cell is in the country of Switzerland[3].
- Tinostamustine Conditioning and Autologous Stem Cell is in the country of United States[4].
- Tinostamustine Conditioning and Autologous Stem Cell's instance of is recorded as clinical trial[5].
- Tinostamustine Conditioning and Autologous Stem Cell's start time is recorded as +2018-09-19T00:00:00Z[6].
- Tinostamustine Conditioning and Autologous Stem Cell's end time is recorded as +2022-06-30T00:00:00Z[7].
- Tinostamustine Conditioning and Autologous Stem Cell's main subject is recorded as multiple myeloma[8].
- Tinostamustine Conditioning and Autologous Stem Cell's number of participants is recorded as {'unit': '1', 'amount': '+71'}[9].
- Tinostamustine Conditioning and Autologous Stem Cell's title is recorded as Phase 1/2 Open-label Trial of Tinostamustine Conditioning and Autologous Stem Cell Transplantation for Salvage Treatment in Relapsed / Refractory Multiple Myeloma (TITANIUM 1)[10].
- Tinostamustine Conditioning and Autologous Stem Cell's short name is recorded as TITANIUM1[11].
- Tinostamustine Conditioning and Autologous Stem Cell's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[12].
- Tinostamustine Conditioning and Autologous Stem Cell's ClinicalTrials.gov ID is recorded as NCT03687125[13].
- Tinostamustine Conditioning and Autologous Stem Cell's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+75'}[14].
- Tinostamustine Conditioning and Autologous Stem Cell's clinical trial phase is recorded as phase I clinical trial[15].
- Tinostamustine Conditioning and Autologous Stem Cell's clinical trial phase is recorded as phase II clinical trial[16].
- Tinostamustine Conditioning and Autologous Stem Cell's research site is recorded as University of Alabama[17].
- Tinostamustine Conditioning and Autologous Stem Cell's research site is recorded as Atrium Health[18].
- Tinostamustine Conditioning and Autologous Stem Cell's research site is recorded as Vanderbilt University[19].
- Tinostamustine Conditioning and Autologous Stem Cell's research site is recorded as The University of Texas MD Anderson Cancer Center[20].
- Tinostamustine Conditioning and Autologous Stem Cell's research site is recorded as University Hospital of Basel[21].
- Tinostamustine Conditioning and Autologous Stem Cell's research subject recruitment status is recorded as terminated[22].
- Tinostamustine Conditioning and Autologous Stem Cell's study type is recorded as interventional study[23].